Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation | Zendy

Takashi Taketa | Zendy; Arlene M. Correa | Zendy; Akihiro Suzuki | Zendy; Mariela A. Blum | Zendy; Pamela L. Chien | Zendy; Jeffrey H. Lee | Zendy; James W. Welsh | Zendy; Steven H. Lin | Zendy; Dipen M. Maru | Zendy; Jeremy J. Erasmus | Zendy; Manoop S. Bhutani | Zendy; Brian Weston | Zendy; David C. Rice | Zendy; Ara A. Vaporciyan | Zendy; Wayne L. Hofstetter | Zendy; Stephen G. Swisher | Zendy; Jaffer A. Ajani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation

Author(s) -

Takashi Taketa,

Arlene M. Correa,

Akihiro Suzuki,

Mariela A. Blum,

Pamela L. Chien,

Jeffrey H. Lee,

James W. Welsh,

Steven H. Lin,

Dipen M. Maru,

Jeremy J. Erasmus,

Manoop S. Bhutani,

Brian Weston,

David C. Rice,

Ara A. Vaporciyan,

Wayne L. Hofstetter,

Stephen G. Swisher,

Jaffer A. Ajani

Publication year - 2012

Publication title -

oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.987

H-Index - 98

eISSN - 1423-0232

pISSN - 0030-2414

DOI - 10.1159/000341353

Subject(s) - medicine , esophageal cancer , adenocarcinoma , stage (stratigraphy) , surgery , cancer , biopsy , carcinoma , radiation therapy , esophagus , paleontology , biology

For patients with localized esophageal cancer (EC) who can withstand surgery, the preferred therapy is chemoradiation followed by surgery (trimodality). However, after achieving a clinical complete response [clinCR; defined as both post-chemoradiation endoscopic biopsy showing no cancer and physiologic uptake by positron emission tomography (PET)], some patients decline surgery. The literature on the outcome of such patients is sparse.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research